Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Santen Pharmaceutical ADR (OP: SNPHY )

9.830 +0.300 (+3.15%)
Streaming Delayed Price Updated: 2:04 PM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Santen Pharmaceutical ADR

SNPHY Stock Earnings: Santen Pharmaceutical Reported Results for Q4 2023
Santen Pharmaceutical just reported results for the fourth quarter of 2023. 
Via InvestorPlace
Current Analysis: Santen Pharmaceutical
Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. Over the past year, Santen's share price rose about 32% from $7.60 to $10.01 as of Thursday’s market... 
Via Talk Markets
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.